🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Virus Shatters China’s Dream of Overtaking Hollywood in 2020

Published 02/06/2020, 10:17 PM
Updated 02/06/2020, 11:07 PM
Virus Shatters China’s Dream of Overtaking Hollywood in 2020
DIS
-

(Bloomberg) -- Sign up for Next China, a weekly email on where the nation stands now and where it's going next.

China is no longer on track to dethrone the U.S. as the world’s No. 1 movie market this year.

The coronavirus has clobbered the burgeoning Hollywood rival, virtually wiping out ticket sales during the recent seven-day Lunar New Year holiday -- a week that’s been historically the busiest for box-office collections. Theaters across the country have remained shut since Jan. 24, while the fear of infection has prompted people to avoid crowded places.

Losses from the collapse of ticket sales mounted to $1 billion during the festive period, according to estimates by Rance Pow, chief executive officer of cinema industry consulting firm Artisan Gateway. That number is about 10% of the anticipated revenue in 2020, and is set to rise as uncertainty over the outbreak persists.

The impact of a virus that’s killed more than 600 people and slammed the local movie market is likely to spread to Hollywood, which is increasingly relying on Chinese audiences for growth as domestic ticket sales decline. Walt Disney (NYSE:DIS) Co. said this week that the epidemic is a headwind for its studio.

“The loss will do significant financial damage to both theaters and production companies in China, and if theaters remain closed for several more weeks, the financial harm will expand,” said Lindsay Conner, partner and leader of the entertainment consultancy of Los Angeles-based Manatt, Phelps & Phillips. “With Chinese theaters closed due to the outbreak, Hollywood’s plans for distributing new films in China are also uncertain.”

Shares of Wanda Film Holding Co., a cinema operator controlled by billionaire Wang Jianlin, have plunged 27% since Jan. 17. Imax China Holding Inc., which operates giant screens, has tumbled 22%, while Beijing Enlight Media Co., Ltd., one of China’s largest studios, slid 18%.

China has already overtaken the U.S. in terms of numbers of cinema screens following a building boom that helped box-office sales climb sixfold since 2010. Analysts were predicting the market to surpass the U.S. in terms of revenue this year.

Movie ticket sales in the country, excluding booking fees, rose 4.1% last year to 58.9 billion yuan ($8.5 billion), compared with 9.7 billion yuan in 2010. Imported films accounted for about 36% of box office sales last year in China, the largest overseas market for U.S. films.

Exhibitors have said they have set no date for re-opening cinemas. That means potential delays in China for big-ticket films from Hollywood such as Disney’s “Mulan” -- based on a legendary Chinese female warrior -- and Pixar’s “Onward,” which are set for March debuts in the U.S., according to Pow.

For companies such as Disney, the hit is not just on the movie business. Its theme park in Shanghai has closed as well, along with Disneyland in Hong Kong, which had already been hit by the city’s political unrest. Executives at the Burbank, California-based entertainment giant said Tuesday the theme park shutdowns would pare about $175 million off revenue in the current quarter.

Local language movies set to open during the Lunar New Year holiday then canceled included “Detective Chinatown 3,” the third installment of one of China’s most commercially successful comedies, “Leap,” based on the true story of the Chinese women’s volleyball team, and “Jiang Ziya: Legend of Deification.”

“Even if the virus ended today, the backlog of films to release -- all Chinese -- is pretty large,” said Chris Fenton, a film producer and U.S.-Asia Institute trustee. A delay in the China release of “Mulan,” would also raise the question of whether Disney would postpone the U.S. release, he said.

(Updates death toll in fourth paragraph, share prices in sixth paragraph)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.